Evolution of the Average Target: Lemonade, Inc.

Evolution of the Target Price: Lemonade, Inc.

Changes in Analyst Recommendations: Lemonade, Inc.

2bf8.Iz2WEl7MYrKMTxw3FMtNK0R7T9bh5BHxkX5EbhMhjdA.EVGkIHOpB-D2Ayx6bb8_XyI4AqWbhWuc5Sw2Fltv5pNBC6JNDKgt0dl5TQ~f086ddf16b145ff9f68cb09c414a1597
07-30 Keefe Bruyette & Woods Upgrades Lemonade to Market Perform From Underperform, PT is $48 MT
07-08 Lemonade's Share Rally Leaves Limited Upside Without New Catalysts, Morgan Stanley Says MT
07-08 Morgan Stanley Downgrades Lemonade to Equalweight From Overweight, Maintains $75 Price Target MT
06-08 TD Cowen Raises Lemonade Price Target to $55 From $33, Hold Rating Kept MT
03-17 Lemonade Shares Rise After Morgan Stanley Upgrade MT
03-17 Morgan Stanley Upgrades Lemonade to Overweight From Equalweight, Adjusts PTto $85 From $80 MT
01-06 Truist Initiates Lemonade at Buy With $98 Price Target MT
12-16 Lemonade Shares Rise After Morgan Stanley Upgrade MT
12-16 Morgan Stanley Upgrades Lemonade to Equalweight From Underweight, Adjusts Price Target to $85 From $53 MT
13/08/25 Cantor Fitzgerald Initiates Coverage on Lemonade With Overweight Rating, $60 Price Target MT
08/04/25 Lemonade Faces Growth Hurdles Amid Tariffs, Competition, Market Uncertainty, Morgan Stanley Says MT
08/04/25 Morgan Stanley Downgrades Lemonade to Underweight From Equalweight, Adjusts PT to $24 From $35 MT
20/11/24 Morgan Stanley Upgrades Lemonade to Equalweight From Underweight, Raises Price Target to $42 From $23 MT
07/11/24 Keefe Bruyette & Woods Downgrades Lemonade to Underperform, Price Target is $21 MT
31/10/24 Morgan Stanley Lifts Price Target on Lemonade to $15 From $14, Keeps Underweight Rating MT
07/05/24 Jefferies Adjusts Price Target on Lemonade to $16 From $14, Maintains Underperform Rating MT
01/05/24 Morgan Stanley Lifts Price Target on Lemonade to $15 From $14, Keeps Underweight Rating MT
07/11/23 Morgan Stanley Adjusts Price Target on Lemonade to $12 From $11, Maintains Underweight Rating MT
11/10/23 Morgan Stanley Adjusts Price Target on Lemonade to $10 From $15, Maintains Underweight Rating MT
28/09/23 BMO Capital Adjusts Price Target on Lemonade to $9 From $8, Maintains Underperform Rating MT
04/08/23 Piper Sandler Adjusts Price Target on Lemonade to $17 From $18, Maintains Neutral Rating MT
03/08/23 Morgan Stanley Lifts Price Target on Lemonade to $15 From $14, Maintains Underweight Rating MT
20/06/23 Morgan Stanley Initiates Lemonade at Underweight With $14 Price Target, Says Stock Doesn't Reflect Long Path to Profitability MT
09/05/23 Barclays Adjusts Price Target on Lemonade to $17 From $16, Keeps Equalweight Rating MT
04/05/23 BofA Securities Adjusts Lemonade's Price Target to $12 From $14, Keeps Underperform Rating MT

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
+4.86%
-4.83%
-4.03%
-2.77%
+12.24%
-8.94%
+13.47%
+17.51%
+10.3%
Average +4.20%
Weighted average by Cap. +2.77%
See all sector consensus

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
11
Last Close Price
48.57USD
Average target price
61.22USD
Spread / Average Target
+26.05%
High Price Target
92.00USD
Spread / Highest target
+89.42%
Low Price Target
37.00USD
Spread / Lowest Target
-23.82%

Analyst Consensus Detail

Consensus revision (last 18 months)

Analysts covering the company

Keefe Bruyette & Woods
Morgan Stanley
TD Cowen
Truist Securities
Cantor Fitzgerald
Jefferies & Co.
BMO Capital
Piper Sandler
Barclays
BofA Securities
Keefe, Bruyette & Woods
Oppenheimer
JMP Securities
Autonomous Research
Wolfe Research
Trader
Investor
-
Global
-
Quality
ESG MSCI
CCC
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
11
Last Close Price
48.57USD
Average target price
61.22USD
Spread / Average Target
+26.05%

Quarterly revenue - Rate of surprise